French National Registry of Rare Peritoneal Surface Malignancies
RENAPE
1 other identifier
observational
2,171
1 country
33
Brief Summary
Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France. In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database. All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2010
Longer than P75 for all trials
33 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 30, 2016
CompletedFirst Posted
Study publicly available on registry
July 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedAugust 22, 2017
August 1, 2017
8.2 years
June 30, 2016
August 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of rare peritoneal surface malignancies
Collect detailed clinical and histological diagnosis for estimating annual incidence rate
year 5
Secondary Outcomes (1)
Impact of specific treatment strategies
year 5
Study Arms (7)
pseudomyxoma peritonei
Data from pseudomyxoma peritonei cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
peritoneal mesothelioma
Data from peritoneal mesothelioma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
desmoplastic small round cell tumor
Data from desmoplastic small round cell tumor cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
psammocarcinoma
Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
primary peritoneal serous carcinoma
Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
diffuse peritoneal leiomyomatosis
Data from diffuse peritoneal leiomyomatosis cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
appendiceal mucinous neoplasms
Data from appendiceal mucinous neoplasms cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
Interventions
Data collection
Eligibility Criteria
Prospectively or retrospectively diagnosed patients with rare peritoneal surface malignancies.
You may qualify if:
- Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.
You may not qualify if:
- Histological diagnostic of peritoneal surface malignancy not confirmed
- Expected clinical follow up data not available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (33)
Institut de Cancérologie de l'Ouest - Paul Papin
Angers, 49100, France
CHU Jean Minjoz
Besançon, 25030, France
Institut Bergonié
Bordeaux, 33076, France
Centre François Baclesse
Caen, 14076, France
CHU Estaing
Clermont-Ferrand, 63003, France
Centre Jean Perrin
Clermont-Ferrand, 63011, France
AP-HP Louis MOURIER
Colombes, 92700, France
CHU Bocage
Dijon, 21079, France
CHU A. Michallon
La Tronche, 38700, France
Centre Oscar Lambret
Lille, 59020, France
CHRU Claude Huriez
Lille, 59037, France
Centre Léon Bérard
Lyon, 69008, France
Institut Paoli Calmettes
Marseille, 13273, France
Hôpital La Timône
Marseille, 13385, France
Institut du Cancer Montpellier
Montpellier, 34298, France
CHU Nantes Hôtel-Dieu
Nantes, 44093, France
CHU L'Archet II
Nice, 06200, France
Institut Curie
Paris, 75005, France
AP-HP St Antoine
Paris, 75012, France
AP-HP La Pitié-Salpêtrière
Paris, 75013, France
AP-HP Lariboisière
Paris, 75475, France
AP-HP Hôpîtal Europeen Georges Pompidou
Paris, 75908, France
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet,
Pierre-Bénite, 69495, France
CHU Poitiers
Poitiers, 86021, France
Hôpital Robert Debré
Reims, 51092, France
CHU Charles Nicolle
Rouen, ROUEN, France
CHU Nord
Saint-Etienne, 42055, France
Institut Cancérologie de l'Ouest - René Gauducheau
Saint-Herblain, 44805, France
CHRU Hautepierre
Strasbourg, 67098, France
Institut Claudius Regaud
Toulouse, 31052, France
Hôpital Purpan
Toulouse, 31059, France
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
Institut Gustave Roussy
Villejuif, 94805, France
Related Publications (1)
Villeneuve L, Passot G, Glehen O, Isaac S, Bibeau F, Rousset P, Gilly FN; RENAPE Network. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis. 2017 Feb 17;12(1):37. doi: 10.1186/s13023-017-0571-y.
PMID: 28212684DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François-Noël GILLY, Prof
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet, PIERRE-BENITE, FRANCE, 69495
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 8 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2016
First Posted
July 15, 2016
Study Start
October 1, 2010
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
August 22, 2017
Record last verified: 2017-08